Nonetheless, Accenture gained 1% in premarket trading.
Darden Restaurants (DRI) – The parent of Olive Garden and other restaurant chains fell 2.5% in the premarket after reporting in-line quarter results.
Novavax (NVAX) – The drug maker's stock slipped 6.1% in premarket trading after J.P. Morgan Securities downgraded it to "underweight" from "neutral".
Eli Lilly (LLY) – Eli Lilly rose 1.4% in premarket trading after the FDA approved its cancer drug Retevmo for new uses.
FactSet Research (FDS) – The financial information services provider fell 7 cents shy of estimates with adjusted quarterly earnings of $3.13 per share.